NAME MECHANISM INDICATION CONTRAINDICATI ADVERSE/SIDE NURSING RESPONSIBILITIES

OF ACTION ON EFFECTS
Oxytoci The mechanism Indication for Contraindicated to a Increase heart 1. Assess and accurately record
n of action is that the initiation pregnant patient with rate, nausea, maternal vital signs
it direct on of improvement hypersensitivity to vomiting, 2. Continuously monitor
myofibrils of uterine the drug and its increased uterine contractions, fetal and maternal
produces phase contractions to components as well. motility heart rate, and maternal blood
contractions achieve early Contraindicated to a pressure and ECG as well.
characteristic of vaginal pregnant patient with 3. Explain patient the side effects
normal delivery delivery. a cephalopelvic that may occur.
in pregnancy. disproportion, and 4. Monitor patient closely during
when the delivery first and second stage of labor; there
requires conversion is risk of
as in transverse. cervical laceration uterine rupture
Obstetric and maternal and fetal death.
emergencies that 5. Assess fluid intake and output.
favor surgical Watch for signs and symptoms of
intervention the water intoxication.
6. Terminate or discontinue infusion
if hypersensitivity occurs and notify
the Physician immediately
Magnesi magnesium >prevention and >Parenteral Magnesium > Monitor pulse, blood pressure,
um sulphate treatment of administration of the intoxication respirations and ECG frequently
Sulfate depresses the seizure in drug is which includes: throughout administration of
CNS and controls severe pre- contraindicated in >flushing parenteral magnesium sulfate.>
convulsions by eclampsia or patients with heart > sweating Respirations should beat least
blocking release eclampsia blocker myocardial >muscle 16/min before administering.
of acetylcholine >to control damage weakness > Monitor neurologic status before
at the myoneural hypertension > dizziness and throughout therapy.
junction >pain in the > drowsiness >Institute seizure precaution.
chest, back, > muscle >Patellar reflex should be tested
>patients with weakness before administering, if absent, no
aplastic anemia >slowed/shallow additional doses should be
 may require breathing or other administered
platelet breathing trouble
transfusion .
Lidocain Increases Local or Heart block or other •GI disturbances •Monitor vital signs and notify the
e electrical regional conduction •Bradycardia physician of abnormalities.
stimulation anesthetic. disturbances. •Hypotension •Assess patient’s condition before
threshold of Management of Hypovolemia and •Convulsion therapy and reassess regularly
ventricle and His- acute hypersensitivity to •Numbness of thereafter to monitor drug’s
Purkinje system ventricular amide local tongue effectiveness.
by direct action arrhythmias anesthetics. Infection •Muscle twitching •Monitor for possible adverse drug
on tissues, during cardiac or inflammation in •Restlessness reactions.
resulting to manipulation. the area of injection. •Nervousness •Assess for renal and urinary status.
decrease Control of •Dizziness •Monitor CNS function.
depolarization, status •Blurred vision •Monitor blood levels and report
automaticity and epilepticus •Lightheadedness abnormal results
excitability in refractory •Drowsiness
ventricles during toother •Euphoria
diastolic phase treatments •Vomiting